
Thank you for your interest.
Recruitment for the Tapestry Study is now closed.

Study Locations
More information is also available at: clinicaltrials.gov, identifier NCT04895215.
Find a study location near you
All travel and other expenses for this study will be reimbursed.

UNITED STATES
ALABAMA
Harmonex Neuroscience Research
408 Healthwest Drive
Dothan, AL, 36303
+1 334-836-2000
ARIZONA
University of Arizona
Department of Pediatrics
PO Box 210158,
Room 510, Tucson, Arizona
85721
+1 520-626-1994
Southwestern Autism Research and Resource Center
2225 N 16th St, Phoenix, Arizona, 85006
+1 602-340-8717
CALIFORNIA
Cortica Marin
4000 Civic Center Drive, Ste 100, San Rafael, California 94903
+1 707-582-5406
Cortica Westlake Village
2625 Townsgate Rd, Westlake Village, California, 91361
+1 805-601-7983
COLORADO
IMMUNOe Research Centers
6801 South Yosemite Street,
Centenniel, CO, 80112
+1 303-771-9000
CONNECTICUT
Yale University, Child Study Center
230 S Frontage Rd, New Haven, Connecticut, 06510
+1 203-688-5997
FLORIDA
CNS Solutions, Inc.
5200 Belfort Rd, Ste 420, Jacksonville, Florida, 32256 420
+1 904-281-5757
CNS Solutions, Inc.
618 E South St, Orlando, Florida, 32801
+1 407-425-5100
Contact: Brad Littlejohn, MA, LMHC, CCRC
University of South Florida
3515 E Fletcher Ave, Tampa, Florida, 33613
+1 813-821-8032
ILLINOIS
AMR-Baber Research, Inc.
1460 Bond St, Naperville, Illinois, 60563
+1 630-272-4844
MISSOURI
University of Missouri
Thompson Center for Autism & Neurodevelopmental Disorders
205 Portland Sr
Columbia, MO 65201
+1 573-882-1481
NEVADA
Clinical Research of Southern Nevada, LLC.
7351 Prairie Falcon Rd, Ste 160, Las Vegas, Nevada, 89128
+1 702-838-0742
NEW YORK
Nathan S. Kline Institute for Psychiatric Research
140 Old Orangeburg Rd, Orangeburg, New York, 10962
+1 845-398-2184
Spectrum Neuroscience and Treatment Institute
901 5th Avenue, New York, NY 10021
+1 646-351-0220
OHIO
Ohio State University, Nisonger Center
1581 Dodd Dr, Columbus, Ohio, 43210
+1 614-336-1715
TENNESSEE
Vanderbilt University Medical Center, Psychiatry
1500 21st Avenue South, Suite 2200,
Nashville, 37212
+1 615-295-8591
Texas
Relaro Medical Trials
12801 N. Central Expressway, Suite 350
Dallas, TX, 75243
+1 469-665-8290

AUSTRALIA
Queensland Children's Hospital
Centre for Clinical Trials in Rare Neurodevelopmental Disorders (CCTRND)
62 Graham St, South Brisbane, Brisbane, Queensland, 4101
+61 (0)7 3069 7532
The Children's Hospital at Westmead
Corner Hawkesbury Road and Hainsworth St, Westmead NSW 2145
+61 (0)2 9114 4189 (ext# 44189)
The Royal Children's Hospital
50 Flemington Rd, Parkville, Melbourne, Victoria, 3052
+61 (0)3 9936 6756
Brain Mind Centre
94-100 Mallet St
Sydney, NSW, 2050
+61 (0)2 9114 4189 (ext# 44189)
Monash Kids Research
Level 4, Ward 4F, Monash Children’s Hospital
246 Clayton Road
Clayton, Victoria, 3168
+61 (0)4 6042 7011
NEW ZEALAND
Optimal Clinical Trials,
Level 2/97 Grafton Road, Grafton, Auckland 1010, New Zealand
+64 (0)9 303 4987
“The lack of safe and effective treatment options for co-occurring conditions associated with ASD, such as irritability and anxiety, exacerbate the daily challenges faced by children and their families. I am encouraged by previous studies of AB-2004 and I look forward to assessing its potential as a safe alternative to atypical antipsychotics currently used to treat irritability associated with autism.”
-Robert L. Hendren, D.O., professor, psychiatry, Weill Institute for Neurosciences at the University of California, San Francisco, School of Medicine, and a principal investigator for the AB-2004 Phase 2 trial
